These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3794548)

  • 1. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.
    Golper TA; Feingold KR; Fulford MH; Siperstein MD
    J Lipid Res; 1986 Oct; 27(10):1044-51. PubMed ID: 3794548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cholesterol metabolism in experimental nephrotic syndrome.
    al-Shurbaji A; Humble E; Rudling M; Lindenthal B; Berglund L
    Lipids; 1998 Feb; 33(2):165-9. PubMed ID: 9507238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia.
    Golper TA; Swartz SH
    Metabolism; 1982 May; 31(5):471-6. PubMed ID: 7078427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid metabolism in daunomycin-induced nephrotic rats (5)].
    Gomikawa S; Inagaki O; Mori H; Fujita Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):985-93. PubMed ID: 2263029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs.
    Kwong LK; Feingold KR; Peric-Golia L; Le T; Karkas JD; Alberts AW; Wilson DE
    Diabetes; 1991 Dec; 40(12):1630-9. PubMed ID: 1756903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.
    Vaziri ND; Liang KH
    Kidney Int; 1995 Dec; 48(6):1979-85. PubMed ID: 8587261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
    Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
    Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.
    Patel DD; Knight BL
    Eur J Biochem; 1985 Nov; 153(1):117-23. PubMed ID: 4065145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of plasma mevalonate in rats and humans.
    Kopito RR; Weinstock SB; Freed LE; Murray DM; Brunengraber H
    J Lipid Res; 1982 May; 23(4):577-83. PubMed ID: 7097123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of mevalonate in the hypercholesterolemia seen in experimental chronic renal failure.
    Subang MC; Stewart-Phillips JL; Pappu AS; Subang R; Gagnon RF
    Nephron; 1995; 69(2):151-4. PubMed ID: 7723897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative role of different embryonic tissues in mevalonate metabolism by sterol and nonsterol pathways. Relationship with enzyme activities of cholesterogenesis.
    Marco C; González-Pacanowska D; Segovia JL; García-Peregrín E
    Biochim Biophys Acta; 1986 Sep; 878(2):238-42. PubMed ID: 3019412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
    Sawamura M; Nara Y; Yamori Y
    J Biol Chem; 1992 Mar; 267(9):6051-5. PubMed ID: 1556116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of mevalonic acid, sterols and bile acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in the liver of rabbits with experimental hypercholesterolemia].
    Klimov AN; Poliakova ED; Vasil'eva LE; Denisenko TV; Dizhe EB
    Biokhimiia; 1987 Feb; 52(2):239-46. PubMed ID: 2882784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of cholesterol synthesis in rat liver as induced by 4-methyl-5-hydroxy valeric acid.
    Díaz-Zagoya JC; Hurtado ME; González J
    Experientia; 1976 Sep; 32(9):1138-40. PubMed ID: 971744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic cholesterogenesis by polar steroids accumulated after cholesterol feeding.
    Aguilera JA; García-Molina V; Arce V; García-Peregrín E
    Biosci Rep; 1988 Apr; 8(2):155-62. PubMed ID: 3408811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
    Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T
    Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of thyroid hormone status on mevalonate metabolism in rats.
    Feingold KR; Wiley MH; MacRae G; Siperstein MD
    J Clin Invest; 1980 Oct; 66(4):646-54. PubMed ID: 7419712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid synthesis. VI. Regulation of cholesterol 7 alpha-hydroxylase by taurocholate and mevalonate.
    Pandak WM; Vlahcevic ZR; Chiang JY; Heuman DM; Hylemon PB
    J Lipid Res; 1992 May; 33(5):659-68. PubMed ID: 1619360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.
    Chmielewski M; Sucajtys E; Swierczynski J; Rutkowski B; Bogusławski W
    Mol Cell Biochem; 2003 Apr; 246(1-2):187-91. PubMed ID: 12841361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.